Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...
Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.
In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...
Artificial intelligence (AI) can accelerate drug development, reduce costs, and improve treatment efficacy, but faces challenges like data quality and regulatory hurdles. Over 900 FDA-approved ...
Led by Rock Springs Capital with participation by funds and accounts advised by T. Rowe Price Associates, Inc., Andreessen Horowitz, and other major investors BURLINGAME, Calif.--(BUSINESS ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
In this interview, Dr. Malika Bsibsi discusses the role of iPSC models in advancing neuroscience drug discovery, focusing on neurodegeneration, neuroinflammation, and innovative in vitro approaches.
Contract development and manufacturing organization (CDMO) Abzena has announced the formation of a strategic partnership with biotechnology firm Mabqi.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback